[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619999":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":34,"centralContacts":39,"locations":48,"responsibleParty":76,"collaborators":10,"id":78,"slug":10,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":10,"eligibilityCriteria":82,"healthyVolunteers":79,"sex":83,"minAge":84,"maxAge":10,"enrollmentInfo":85,"targetDuration":10,"studyType":88,"phases":10,"briefSummary":89,"conditions":90,"keywords":94,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Thammasat University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Mild-to-moderate asthma",null,"Patients aged 18 years or older with mild-to-moderate asthma. Mild asthma refers to asthma patients who experience symptoms \\\u003C3 times per week, have preserved lung function (FEV₁ or PEF \\>80% of predicted), and whose symptoms can be adequately controlled with low-dose inhaled corticosteroids (low-dose ICS) alone, without the need for long-acting bronchodilators or other controller medications.\n\nModerate asthma refers to asthma patients who have symptoms \\>4-5 days per week or experience nocturnal asthma symptoms \\>1 per week, and who require treatment with medium-dose inhaled corticosteroids (medium-dose ICS) or low-dose ICS in combination with a long-acting β₂-agonist (low-dose ICS\u002FLABA) to achieve symptom control and prevent exacerbations.",[13,14,15,16],"Other: Global Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnaires","Other: Spirometry","Other: Fractional exhaled nitric oxide (FeNO) test","Other: Blood eosinophil count (BEC)",[18,22,26,30],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"Global Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnaires","GINA and ACT are questionnaires used to assess the level of asthma control.",[9],{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"Spirometry","Spirometry is a tool used to assess pulmonary function.",[9],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":10},"Fractional exhaled nitric oxide (FeNO) test","FeNO is a tool used to assess eosinophilic airway inflammation and asthma remission.",[9],{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":10},"Blood eosinophil count (BEC)","BEC is a tool used to assess eosinophilic inflammation and asthma remission.",[9],[35],{"name":36,"affiliation":37,"role":38},"Narongkorn Saiphoklang, MD","Thammasat University Faculty of Medicine","PRINCIPAL_INVESTIGATOR",[40,44],{"name":36,"role":41,"phone":42,"phoneExt":10,"email":43},"CONTACT","+6629269794","M_narongkorn@hotmail.com",{"name":45,"role":41,"phone":46,"phoneExt":10,"email":47},"Sirashat Hanvivattanakul, MD","+6629269701","boss32_@hotmail.com",[49,66],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Narongkorn Saiphoklang","RECRUITING","Pathum Thani","Changwat Pathum Thani","12120","Thailand",{"type":57,"coordinates":58},"Point",[59,60],100.53049,14.01346,{"lat":60,"lon":59},[63,64,65],{"name":36,"role":41,"phone":42,"phoneExt":10,"email":43},{"name":45,"role":41,"phone":42,"phoneExt":10,"email":47},{"name":36,"role":38,"phone":10,"phoneExt":10,"email":10},{"facility":67,"status":51,"city":52,"state":10,"zip":54,"country":55,"cosmosGeoPoint":68,"geoPoint":70,"contacts":71},"Faculty of Medicine, Thammasat University",{"type":57,"coordinates":69},[59,60],{"lat":60,"lon":59},[72,74,75],{"name":36,"role":41,"phone":73,"phoneExt":10,"email":43},"029269794",{"name":45,"role":41,"phone":46,"phoneExt":10,"email":47},{"name":36,"role":38,"phone":10,"phoneExt":10,"email":10},{"type":38,"investigatorFullName":36,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Associate Professsor","100619999",false,"NCT07351916","Remission in Adults With Mild-to-moderate Asthma in Thailand","Inclusion Criteria:\n\n* mild-to-moderate asthma\n* age 18 years or older\n\nExclusion Criteria:\n\n* inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test","ALL","18 Years",{"count":86,"type":87},289,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand.\n\nThe main question the study aims to answer is:\n\nWhat is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.",[91,92,93],"Asthma","Mild-to-moderate Asthma","Asthma Control Level",[95,96,97,55,98,99,100],"asthma","asthma control","mild-to-moderate asthma","remission","FeNO","blood eosinophil count","2026-04-15",{"date":103,"type":104},"2026-04-17","ACTUAL",{"date":106,"type":104},"2026-02-01",{"date":108,"type":87},"2026-12-31",{"name":5,"class":6},2]